ACR 2020 Debate: JAK Inhibitors vs Biologics After Methotrexate Failure in RA
Experts at the ACR Convergence conference discussed the use of Janus kinase inhibitors before/after biologics following methotrexate treatment failure in RA.
ACR Convergence 2020
Belimumab Plus Standard Therapy Improves Renal Outcomes in Patients With Active Lupus Nephritis
Researchers evaluated the safety and efficacy of belimumab plus standard therapy in patients with active lupus nephritis.
Study Supports Safety, Efficacy of Tofacitinib in the Treatment of Ankylosing Spondylitis
Researchers evaluated the safety and efficacy of tofacitinib for the treatment of patients with ankylosing spondylitis.
Cross-Cutting Disease Factors Predictive of Mental Health in Youth With Rheumatologic Disease
Study authors identified cross-cutting disease factors affecting the mental health of youth with rheumatologic disease.
Assessing the Effect of Cannabis Use on Pain in Rheumatic Diseases
Study authors conducted a systematic review to assess the use of cannabis and its impact on pain in patients with rheumatic diseases.
Comparative Performance of Sodium-Glucose Cotransporter-2 Inhibitors in Reducing Gout in Type 2 Diabetes
Researchers compared the beneficial effect of sodium-glucose cotransporter-2 (SGLT2) inhibitors on gout risk in patients with type 2 diabetes.
Assessing the Long-Term Safety and Efficacy of Tocilizumab in Systemic Sclerosis
The long-term safety and efficacy of tocilizumab in patients with systemic sclerosis were assessed in an open-label study.
Low LDL Associated With Coronary Atherosclerosis Burden, CVD Risk in Non-Obese Patients With RA
Burden and progression of coronary atherosclerosis was found to be worsened in non-obese patients with rheumatoid arthritis and low vs high LDL levels.
Avacopan Superior to Standard Therapy in Renal Function in ANCA-Associated Vasculitis
Study authors evaluated the effect of complement C5a receptor inhibitor avacopan on renal function in ANCA-associated vasculitis.
Healthcare Providers Recognize Potential Benefits of Telemedicine in Pediatric Rheumatology During the COVID-19 Pandemic
During the COVID-19 pandemic, healthcare teams have realized the potential of telemedicine in pediatric rheumatology practices.
-
Loading...
-
Loading...
Next post in ACR Convergence 2020
